Related Experiment Video
Updated: Apr 3, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Obesity Impairs Skeletal Muscle Regeneration Through Inhibition of AMPK
Xing Fu1, Meijun Zhu2, Shuming Zhang2
1Washington Center for Muscle Biology, Department of Animal Sciences and Department of Pharmaceutical Sciences, Washington State University, Pullman, WA.
Abstract:
Obesity is increasing rapidly worldwide and is accompanied by many complications, including impaired muscle regeneration. The obese condition is known to inhibit AMPK activity in multiple tissues. We hypothesized that the loss of AMPK activity is a major reason for hampered muscle regeneration in obese subjects. We found that obesity inhibits AMPK activity in regenerating muscle, which was associated with impeded satellite cell activation and impaired muscle regeneration. To test the mediatory role of AMPKα1, we knocked out AMPKα1 and found that both proliferation and differentiation of satellite cells are reduced after injury and that muscle regeneration is severely impeded, reminiscent of hampered muscle regeneration seen in obese subjects. Transplanted satellite cells with AMPKα1 deficiency had severely impaired myogenic capacity in regenerating muscle fibers. We also found that attenuated muscle regeneration in obese mice is rescued by AICAR, a drug that specifically activates AMPK, but AICAR treatment failed to improve muscle regeneration in obese mice with satellite cell-specific AMPKα1 knockout, demonstrating the importance of AMPKα1 in satellite cell activation and muscle regeneration. In summary, AMPKα1 is a key mediator linking obesity and impaired muscle regeneration, providing a convenient drug target to facilitate muscle regeneration in obese populations.
Insights
Obesity impairs muscle regeneration by inhibiting AMPK activity, particularly AMPKα1 in satellite cells. Restoring AMPK activity with AICAR can rescue this impairment, highlighting AMPKα1 as a therapeutic target for obesity-related muscle issues.
Area of Science:
- Muscle biology
- Metabolic disorders
- Cellular signaling
Background:
- Obesity is a global health crisis linked to numerous complications, including compromised muscle repair.
- Reduced AMP-activated protein kinase (AMPK) activity is a hallmark of obesity across various tissues.
- The precise mechanisms by which obesity-induced AMPK inhibition affects muscle regeneration remain unclear.
Purpose of the Study:
- To investigate the role of AMPK activity in obesity-associated muscle regeneration deficits.
- To determine if AMPKα1 is a critical mediator in this process.
- To evaluate AICAR as a potential therapeutic agent for improving muscle regeneration in obese individuals.
Main Methods:
- Comparative analysis of muscle regeneration in obese and lean mice.
- Genetic manipulation to specifically knock out AMPKα1 in satellite cells.
- Assessment of satellite cell activation, proliferation, and differentiation post-injury.
- Functional evaluation of muscle regeneration following AICAR treatment in different genetic contexts.
Main Results:
- Obesity was confirmed to inhibit AMPK activity in regenerating muscle, correlating with impaired satellite cell function and regeneration.
- Satellite cell-specific AMPKα1 knockout mimicked the regenerative deficits observed in obesity, reducing satellite cell proliferation and differentiation.
- AICAR treatment successfully rescued muscle regeneration in obese mice but not in those with satellite cell-specific AMPKα1 knockout.
- Transplantation of AMPKα1-deficient satellite cells demonstrated severely impaired myogenic capacity.
Conclusions:
- AMPKα1 is a crucial mediator linking obesity to impaired muscle regeneration.
- Targeting AMPKα1 within satellite cells offers a promising therapeutic strategy for enhancing muscle repair in obese populations.
- AMPK activation represents a viable approach to counteract obesity-induced muscle regeneration defects.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

